Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Altus Spine and Joint Pain Center Partners with Regenexx to Bring Revolutionary Non-Surgical Pain Management to the Rio Grande Valley


News provided by

Altus Spine and Joint Pain Center

Sep 30, 2024, 08:00 ET

Share this article

Share toX

Share this article

Share toX


Altus Spine and Joint Pain Center is proud to announce a strategic partnership with Regenexx, a leader in regenerative medicine, to offer advanced, non-surgical treatment options to patients across the Rio Grande Valley.

MCALLEN, Texas, Sept. 30, 2024 /PRNewswire-PRWeb/ -- Altus Spine and Joint Pain Center is proud to announce a strategic partnership with Regenexx®, a leader in regenerative medicine, to offer its advanced, research-driven treatments across the Rio Grande Valley, with a particular focus on McAllen and Mission, Texas.

This collaboration will provide eligible local patients with non-invasive alternatives to traditional orthopedic surgery that harness the body's innate healing capabilities. These treatments use bone marrow concentrate to deliver the body's own cells to the point of injury, promoting natural healing, reducing inflammation, and offering a compelling alternative to surgery.

The Rio Grande Valley deserves access to the best and most advanced healthcare solutions. By partnering with Regenexx, we are bringing a groundbreaking, non-surgical treatment option to our community. Our goal is to empower patients in McAllen, Mission, and beyond.

Post this

This innovative approach aligns perfectly with Altus's mission to provide holistic, patient-centered care that goes beyond conventional pain management techniques and a reliance on pills.

Transforming Pain Management in the Rio Grande Valley

Dr. Jaime Sued, founder of Altus Spine and Joint Pain Center, shared his enthusiasm for the partnership, stating, "The Rio Grande Valley deserves access to the best and most advanced healthcare solutions. By partnering with Regenexx, we are bringing a groundbreaking, non-surgical treatment option to our community. Our goal is to empower patients in McAllen, Mission, and beyond to take control of their pain and improve their quality of life without the need for invasive procedures."

Meeting the Needs of the Local Community

The Rio Grande Valley is experiencing a growing demand for effective pain management solutions that do not rely solely on surgery or long-term medication. The introduction of Regenexx procedures at Altus responds directly to this need, offering a safe, research-backed alternative that addresses the root cause of pain rather than just the symptoms. This partnership ensures that residents have access to the latest advancements in regenerative medicine, right in their own community.

Customized, Patient-Focused Care

Altus Spine and Joint Pain Center has long been recognized for its commitment to personalized care. With the addition of Regenexx, Altus can now offer even more tailored treatment plans, combining the expertise of its multidisciplinary team with the cutting-edge technology of regenerative medicine. Patients can expect a comprehensive approach to pain management that not only alleviates pain but also improves overall wellness and quality of life.

Scheduling a Consultation

Residents of McAllen, Mission, and the broader Rio Grande Valley who are interested in learning more about Regenexx procedures or determining their candidacy for this non-surgical treatment are encouraged to schedule a consultation with an Altus physician. During the consultation, the team will assess each patient's condition, discuss the potential benefits of Regenexx, and help patients make informed decisions about their pain management options.

To schedule an appointment or for more information, patients can visit Altus Spine and Joint Pain Center or call (210) 449-1029.

About Altus Spine and Joint Pain Center

Founded by Dr. Jaime Sued, Altus Spine and Joint Pain Center is dedicated to providing innovative, evidence-based treatments for chronic pain. With a focus on the unique needs of the Rio Grande Valley, Altus offers a holistic approach that goes beyond medication, empowering patients to take control of their pain and improve their quality of life through personalized, integrative care that includes everything from nutritional counseling to physical therapy.

About Regenexx

Regenexx is a pioneer in the field of regenerative medicine, offering non-surgical treatment options that utilize the body's natural healing abilities. Since 2005, Regenexx has been at the forefront of interventional orthopedics, performing more than 190,500 procedures and significantly contributing to the global research on bone marrow concentrate for orthopedic conditions.

Media Contact

Joan James-Collins, CODESM, 1 9562753343, [email protected], https://www.codesm.com/

SOURCE Altus Spine and Joint Pain Center

Modal title

Regenexx
Regenexx
Regenexx logo
Regenexx logo
Altus logo
Altus logo
Regenexx Regenexx logo Altus logo

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.